BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 21, 2016
View Archived Issues
New phase I trial explores use of WOKVAC vaccine to prevent breast cancer recurrence
Read More
NIH award supports pancreatic cancer study of CivaSheet
Read More
Zydus Cadila and Takeda Pharmaceutical partner to tackle chikungunya
Read More
NCI awards contract to BioMarker Strategies for predictive test in NSCLC
Read More
ResistancePlus MG assay awarded CE-IVD mark
Read More
U.S. phase I study of oral OTS-167 to begin in breast cancer
Read More
Adgero Biopharmaceuticals obtains financing to support development of REM-001
Read More
MabVax Therapeutics gives update on phase I study of MVT-5873
Read More
Prozymex patents DPPI inhibitors
Read More
Teva and Regeneron enter global collaboration to develop and commercialize fasinumab
Read More
Asthma exacerbation model mimics the effects of viral respiratory infections
Read More
Amgen's phase III GLAGOV study of evolocumab meets endpoints
Read More
Sunovion Pharmaceuticals reports results from pivotal trial of dasotraline in ADHD
Read More
BioLineRx begins phase IIa study of BL-8040 plus pembrolizumab in pancreatic cancer
Read More
Danish scientists disclose DNA gyrase and topoisomerase IV inhibitors
Read More
EMA validates BMS' application to extend Opdivo indications
Read More
Long-acting growth hormone CJ-40002 is safe and effective in phase I trial
Read More
Amgen describes Nav1.7 channel blockers
Read More
Mirna Therapeutics stops phase I trial of MRX-34 following immune-related severe adverse events
Read More
BioNTech and Genentech to develop individualized mRNA-based cancer vaccines
Read More
Allergan to acquire Tobira Therapeutics
Read More
FDA grants fast track designation to Viaskin Milk
Read More
Phase III study of vepoloxamer in sickle cell disease does not meet primary efficacy endpoint
Read More
Bionomics reports promising phase II results for BNC-210 in generalized anxiety disorder
Read More
Kite Pharma signs license with NIH to target KRAS driven cancers
Read More
Serum NFL shows promise as a biomarker in RRMS
Read More
FDA grants orphan drug designation to CC-122
Read More
Follistatin gene therapy receives FDA orphan designation for inclusion body myositis
Read More
New biomarkers could help differentiate CIS patients from other forms of multiple sclerosis
Read More